» Articles » PMID: 36761493

Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)

Overview
Specialty Pediatrics
Date 2023 Feb 10
PMID 36761493
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose of developing the guidelines: Newborn screening (NBS) for congenital hypothyroidism (CH) was started in 1979 in Japan, and early diagnosis and treatment improved the intelligence prognosis of CH patients. The incidence of CH was once about one in 5,000-8,000 births, but has been increased with diagnosis of subclinical CH. The disease requires continuous treatment and specialized medical facilities should conduct differential diagnosis and treatment in patients who are positive by NBS to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, the guidelines were revised in 2014. Here, we have added minor revisions to the 2014 version to include the most recent findings. Target disease/conditions: Primary congenital hypothyroidism Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.

Citing Articles

Pseudohypoparathyroidism type 1A presenting as short stature and congenital hypothyroidism.

Kondetimmanahalli R, Lynch J, Francis G, Gardner H, Pillai R Endocrinol Diabetes Metab Case Rep. 2025; 2025(1).

PMID: 39868553 PMC: 11811821. DOI: 10.1530/EDM-24-0097.


Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start.

Arrigoni M, Zwaveling-Soonawala N, LaFranchi S, van Trotsenburg A, Mooij C Eur Thyroid J. 2025; 14(1).

PMID: 39812367 PMC: 11816049. DOI: 10.1530/ETJ-24-0327.


Age of menarche and final height in patients with permanent congenital hypothyroidism.

Karimian P, Hovsepian S, Alinia T, Raispour H, Mirshahzadeh N, Hashemipour M Ann Pediatr Endocrinol Metab. 2025; 29(6):371-378.

PMID: 39778406 PMC: 11725635. DOI: 10.6065/apem.2448014.007.


Newborn Screening for Six Primary Conditions in a Clinical Setting in Morocco.

El Janahi S, Filali M, Boudar Z, Akhattab A, Jaoudi R, Al Idrissi N Int J Neonatal Screen. 2024; 10(4).

PMID: 39728400 PMC: 11677151. DOI: 10.3390/ijns10040080.


Newborn Genetic Screening Improves the Screening Efficiency for Congenital Hypothyroidism: A Prospective Multicenter Study in China.

Ye L, Zhang Y, Feng J, Huang C, Wang X, Han L Int J Neonatal Screen. 2024; 10(4).

PMID: 39728398 PMC: 11678242. DOI: 10.3390/ijns10040078.


References
1.
van Trotsenburg A, Vulsma T, Rutgers van Rozenburg-Marres S, van Baar A, Ridder J, Heymans H . The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab. 2005; 90(6):3304-11. DOI: 10.1210/jc.2005-0130. View

2.
Salerno M, Micillo M, Di Maio S, Capalbo D, Ferri P, Lettiero T . Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol. 2001; 145(4):377-83. DOI: 10.1530/eje.0.1450377. View

3.
Rovet J, Ehrlich R . Long-term effects of L-thyroxine therapy for congenital hypothyroidism. J Pediatr. 1995; 126(3):380-6. DOI: 10.1016/s0022-3476(95)70452-3. View

4.
Ohnishi H, Sato H, Noda H, Inomata H, Sasaki N . Color Doppler ultrasonography: diagnosis of ectopic thyroid gland in patients with congenital hypothyroidism caused by thyroid dysgenesis. J Clin Endocrinol Metab. 2003; 88(11):5145-9. DOI: 10.1210/jc.2003-030743. View

5.
Panoutsopoulos G, Mengreli C, Ilias I, Batsakis C, Christakopoulou I . Scintigraphic evaluation of primary congenital hypothyroidism: results of the Greek screening program. Eur J Nucl Med. 2001; 28(4):529-33. DOI: 10.1007/s002590100491. View